Chronic myeloid leukemia lysate-loaded dendritic cells induce T-cell responses towards leukemia progenitor cells. Apr 2011 - Immunotherapy; 3(4):1750-7448 [PMID:21463196] [Westers TM] [van den Ancker W] [Bontkes HJ] [Janssen JJ] [van de Loosdrecht AA] [Ossenkoppele GJ]
Dendritic cell-based immunotherapy in myeloid leukaemia: translating fundamental mechanisms into clinical applications. Dec 2008 - Handb Exp Pharmacol(188):0171-2004 [PMID:19031033] [van de Loosdrecht AA] [van den Ancker W] [Houtenbos I] [Ossenkoppele GJ] [Westers TM]
Dendritic cell-based immunotherapy in acute and chronic myeloid leukaemia. Sep 2007 - Biomed. Pharmacother.; 61(6):0753-3322 [PMID:17368821] [Westers TM] [Ossenkoppele GJ] [van de Loosdrecht AA]
Feasibility of clinical dendritic cell vaccination in acute myeloid leukemia. Sep 2006 - Immunobiology; 211(6-8):0171-2985 [PMID:16920506] [Houtenbos I] [Westers TM] [Ossenkoppele GJ] [van de Loosdrecht AA]
